Ardelyx
ARDX

$5.99

1.53%

Market Cap: $1.41B

About: Ardelyx Inc is a biotechnology company focused on the discovery, development, and commercialization of innovative, first-in-class medicines that meet significant unmet medical needs. The company has a proprietary drug discovery and design platform. Its lead product candidate is tenapanor, which aims to reduce the absorption of dietary sodium and phosphorus for the treatment of kidney disease, irritable bowel syndrome with constipation, and hyperphosphatemia in patients with dialysis.

Employees: 267

Healthcare Pharmaceutical Preparations

0

Funds holding %

of 6,710 funds

0

Analysts bullish %

of 6 analysts

Fund manager confidence

Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)

100% more funds holding in top 10

Funds holding in top 10: 2 [Q1] → 4 (+2) [Q2]

17% more first-time investments, than exits

New positions opened: 41 | Existing positions closed: 35

10% more repeat investments, than reductions

Existing positions increased: 66 | Existing positions reduced: 60

3% more funds holding

Funds holding: 186 [Q1] → 192 (+6) [Q2]

2% more capital invested

Capital invested by funds: $1.05B [Q1] → $1.07B (+$17.3M) [Q2]

0.24% less ownership

Funds ownership: 61.69% [Q1] → 61.45% (-0.24%) [Q2]

13% less call options, than puts

Call options by funds: $18M | Put options by funds: $20.6M

See Fund Rankings

Research analyst outlook

6 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target

$10

67%

upside

Avg. target

$10.83

81%

upside

High target

$12

100%

upside

6 analyst ratings

6 positive

100%

0 neutral

0%

0 negative

0%

HC Wainwright & Co. Ed Arce 43% 1-year accuracy 60 / 140 met price target	84%upside $11	Buy Maintained	5 Aug 2024
Citigroup Yigal Nochomovitz 45% 1-year accuracy 17 / 38 met price target	100%upside $12	Buy Maintained	2 Aug 2024
Wedbush Laura Chico 50% 1-year accuracy 37 / 74 met price target	84%upside $11	Outperform Reiterated	2 Aug 2024
HC Wainwright & Co. Ed Arce 43% 1-year accuracy 60 / 140 met price target	67%upside $10	Buy Reiterated	18 Jul 2024
Wedbush Laura Chico 50% 1-year accuracy 37 / 74 met price target	84%upside $11	Outperform Reiterated	18 Jul 2024

See Analyst Rankings

Financial journalist opinion

Based on 251 articles about ARDX published over the past 30 days

Shareholders of Ardelyx, Inc. Should Contact Levi & Korsinsky Before October 15, 2024 to Discuss Your Rights - ARDX

NEW YORK, NY / ACCESSWIRE / September 20, 2024 / If you suffered a loss on your Ardelyx, Inc. (NASDAQ:ARDX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/ardelyx-lawsuit-submission-form?prid=103998&wire=1 or contact Joseph E. Levi, Esq.

Shareholders of Ardelyx, Inc. Should Contact Levi & Korsinsky Before October 15, 2024 to Discuss Your Rights - ARDX

ARDX SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Ardelyx, Inc. Stockholders Have Opportunity to Lead Class Action Lawsuit!

NEW YORK CITY, NY / ACCESSWIRE / September 20, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Ardelyx, Inc. ("Ardelyx" or "the Company") (NASDAQ:ARDX) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Ardelyx securities between October 31, 2023, and July 1, 2024, inclusive (the "Class Period").

ARDX SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Ardelyx, Inc. Stockholders Have Opportunity to Lead Class Action Lawsuit!

Levi & Korsinsky Notifies Ardelyx, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - ARDX

NEW YORK , Sept. 20, 2024 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Ardelyx, Inc. ("Ardelyx" or the "Company") (NASDAQ: ARDX) of a class action securities lawsuit.

Levi & Korsinsky Notifies Ardelyx, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - ARDX

Ardelyx, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before October 15, 2024 to Discuss Your Rights – ARDX

NEW YORK, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Ardelyx, Inc. ("Ardelyx" or the "Company") (NASDAQ: ARDX) of a class action securities lawsuit.

Ardelyx, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before October 15, 2024 to Discuss Your Rights – ARDX

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of October 15, 2024 in Ardelyx, Inc. Lawsuit - ARDX

NEW YORK, NY / ACCESSWIRE / September 19, 2024 / If you suffered a loss on your Ardelyx, Inc. (NASDAQ:ARDX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/ardelyx-lawsuit-submission-form?prid=103870&wire=1 or contact Joseph E. Levi, Esq.

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of October 15, 2024 in Ardelyx, Inc. Lawsuit - ARDX

Ardelyx Inc Is Being Sued For Possible Securities Law Violations And Impacted Investors Are Urged To Contact The Schall Law Firm

LOS ANGELES, CA / ACCESSWIRE / September 19, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a category motion lawsuit against Ardelyx, Inc. ("Ardelyx" or "the Company") (NASDAQ:ARDX) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between October 31, 2023 and July 1, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before October 15, 2024.

Ardelyx Inc Is Being Sued For Possible Securities Law Violations And Impacted Investors Are Urged To Contact The Schall Law Firm

Ardelyx, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - ARDX

NEW YORK, NY / ACCESSWIRE / September 19, 2024 / If you suffered a loss on your Ardelyx, Inc. (NASDAQ:ARDX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/ardelyx-lawsuit-submission-form?prid=103817&wire=1 or contact Joseph E. Levi, Esq.

Ardelyx, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - ARDX

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Ardelyx, Inc. of Class Action Lawsuit and Upcoming Deadlines - ARDX

NEW YORK, NY / ACCESSWIRE / September 19, 2024 / Pomerantz LLP announces that a class action lawsuit has been filed against Ardelyx, Inc. ("Ardelyx" or the "Company") (NASDAQ:ARDX) and certain officers. The class action, filed in the United States District Court for the District of Massachusetts, and docketed under 24-cv-12119, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Ardelyx securities between October 31, 2023 and July 1, 2024, both dates inclusive (the "Class Period"), seeking to recover damages caused by Defendants' violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the "Exchange Act") and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officers.

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Ardelyx, Inc. of Class Action Lawsuit and Upcoming Deadlines - ARDX

Class Action Filed Against Ardelyx, Inc. (ARDX) Seeking Recovery for Investors - Contact Levi & Korsinsky

NEW YORK, NY / ACCESSWIRE / September 19, 2024 / If you suffered a loss on your Ardelyx, Inc. (NASDAQ:ARDX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/ardelyx-lawsuit-submission-form?prid=103755&wire=1 or contact Joseph E. Levi, Esq.

Class Action Filed Against Ardelyx, Inc. (ARDX) Seeking Recovery for Investors - Contact Levi & Korsinsky

ARDX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Ardelyx, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit!

NEW YORK CITY, NY / ACCESSWIRE / September 19, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Ardelyx, Inc. ("Ardelyx" or "the Company") (NASDAQ:ARDX) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Ardelyx securities between October 31, 2023, and July 1, 2024, inclusive (the "Class Period").

ARDX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Ardelyx, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit!

See News Rankings